National Trends in Psychotropic Medication Use in Young Children: 1994-2009

被引:36
|
作者
Chirdkiatgumchai, Vilawan [1 ,2 ]
Xiao, Hong [1 ]
Fredstrom, Bridget K. [1 ]
Adams, Ryan E. [1 ]
Epstein, Jeff N. [1 ]
Shah, Samir S. [1 ]
Brinkman, William B. [1 ]
Kahn, Robert S. [1 ]
Froehlich, Tanya E. [1 ]
机构
[1] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA
[2] Mahidol Univ, Ramathibodi Hosp, Dept Pediat, Bangkok 10700, Thailand
关键词
psychotropic medications; stimulant medications; psychostimulants; very young children; preschoolers; behavioral disorders; mental health disorders; psychiatric disorders; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; HEALTH-CARE; PRESCHOOL-CHILDREN; PRACTICE PATTERNS; UNITED-STATES; DRUG USE; ADHD; PREVALENCE; RISK; ADOLESCENTS;
D O I
10.1542/peds.2013-1546
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
OBJECTIVE: To examine recent national trends in psychotropic use for very young children at US outpatient medical visits. METHODS: Data for 2- to 5-year-old children (N = 43 598) from the 1994-2009 National Ambulatory and National Hospital Ambulatory Medical Care Surveys were used to estimate the weighted percentage of visits with psychotropic prescriptions. Multivariable logistic regression was used to identify factors associated with psychotropic use. Time effects were examined in 4-year blocks (1994-1997, 1998-2001, 2002-2005, and 2006-2009). RESULTS: Psychotropic prescription rates were 0.98% from 1994-1997, 0.83% from 1998-2001, 1.45% from 2002-2005, and 1.00% from 2006-2009. The likelihood of preschool psychotropic use was highest in 2002-2005 (1994-1997 adjusted odds ratio [AOR] versus 2002-2005: 0.67; 1998-2001 AOR versus 2002-2005: 0.63; 2006-2009 AOR versus 2002-2005: 0.64), then diminished such that the 2006-2009 probability of use did not differ from 1994-1997 or from 1998-2001. Boys (AOR versus girls: 1.64), white children (AOR versus other race: 1.42), older children (AOR for 4 to 5 vs 2 to 3 year olds: 3.87), and those lacking private insurance (AOR versus privately insured: 2.38) were more likely than children from other groups to receive psychotropic prescriptions. CONCLUSIONS: Psychotropic prescription was notable for peak usage in 2002-2005 and sociodemographic disparities in use. Further study is needed to discern why psychotropic use in very young children stabilized in 2006-2009, as well as reasons for increased use in boys, white children, and those lacking private health insurance. Pediatrics
引用
收藏
页码:615 / 623
页数:9
相关论文
共 50 条
  • [41] National Trends in Psychotropic Medication Polypharmacy in Office-Based Psychiatry
    Mojtabai, Ramin
    Olfson, Mark
    ARCHIVES OF GENERAL PSYCHIATRY, 2010, 67 (01) : 26 - 36
  • [42] Patterns of psychotropic medication use in very young children with attention-deficit hyperactivity disorder
    Rappley, MD
    Eneli, IU
    Mullan, PB
    Alvarez, FJ
    Wang, J
    Luo, ZH
    Gardiner, JC
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2002, 23 (01): : 23 - 30
  • [43] Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children
    Rappley, MD
    Mullan, PB
    Alvarez, FJ
    Eneli, IU
    Wang, J
    Gardiner, JC
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 1999, 153 (10): : 1039 - 1045
  • [44] Interstate Variations in Psychotropic Medication Use Among a National Sample of Children in the Child Welfare System
    Raghavan, Ramesh
    Lama, Gyanesh
    Kohl, Patricia
    Hamilton, Barton
    CHILD MALTREATMENT, 2010, 15 (02) : 121 - 131
  • [45] National trends of psychotropic medication use among patients diagnosed with anxiety disorders: Results from Medical Expenditure Panel Survey 2004-2009
    Wu, Chung-Hsuen
    Wang, Chi-Chuan
    Katz, Aaron Jacob
    Farley, Joel
    JOURNAL OF ANXIETY DISORDERS, 2013, 27 (02) : 163 - 170
  • [46] Adverse Drug Effects of Therapeutic Psychotropic Medication in Young Children
    Abdulrahman, E.
    Costello, B.
    Al-Khamees, W.
    DeGuzman, M.
    Geller, R. J.
    CLINICAL TOXICOLOGY, 2009, 47 (07) : 764 - 764
  • [47] Trends in cardiovascular mortality and hospitalisations, and potential contribution of inhospital case-fatality rates to changes in national mortality in the Czech Republic 1994-2009
    Davidkovova, Hana
    Kysely, Jan
    Kriz, Bohumir
    Vojtisek, Petr
    Bobak, Martin
    HEART, 2013, 99 (06) : 409 - 416
  • [48] NATIONAL TRENDS OF PSYCHOTROPIC MEDICATION USE AMONG PATIENTS DIAGNOSED WITH ANXIETY DISORDERS: RESULTS FROM THE MEDICAL EXPENDITURE PANEL SURVEY 2004-2009
    Wu, C. H.
    Wang, C. C.
    Katz, A. J.
    Farley, J.
    VALUE IN HEALTH, 2012, 15 (04) : A83 - A83
  • [49] Psychotropic Medication Use in Children and Adolescents With Down Syndrome
    Downes, Alison
    Anixt, Julia S.
    Esbensen, Anna J.
    Wiley, Susan
    Meinzen-Derr, Jareen
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2015, 36 (08): : 613 - 619
  • [50] Psychotropic Medication Use in Parents of Children Diagnosed With Cancer
    Salem, Hanin
    Andersen, Elisabeth Wreford
    Dalton, Susanne O.
    Schmiegelow, Kjeld
    Winther, Jeanette Falck
    Lichtenthal, Wendy G.
    Johansen, Christoffer
    Bidstrup, Pernille E.
    PEDIATRICS, 2019, 143 (05)